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There are many reports concerning the homogenous grafting of the
ovary to the women with dysfunction of the ovary such as those by
MORRIS, UNTERBERGER, GUNSTER, SCRULTZE, and ORNO. Differing from
the case of grafting to the castrated women, in this case we are after the
cure of peculiar ovarian function by grafting. Because success or failure
of grafting itself was described in Part 1, in the present paper an attempt
has been made to evaluate the efficacy of grafting by pursuing the effect
for a long period of time continuously with the use of as many examina-
tion methods as possible.
MATERIALS AND METHODS
Subjects receiving grafting: Homogenous grafting of the ovary
was performed on 16 cases who first had been diagnosed as dysfunction
of the ovary and finally diagnosed definitely after follow-up examinations
for two months by various methods of examination mentioned in the fol-
lowing manners (Table 2).
Donors of the ovary: Ovaries were selected exactly in the same
manner as in Part 1 from women of 28 to 45 years old.
The method of grafting: In principle the method of grafting was
the same as used in Part 1, except for a larger ovary which was sliced
into thin section before grafting. Namely, immediately on removing the
ovary is immersed in penicilin solution and is treated in the same manner
as previously reported and is grafted after local anesthesia. The patient
is made to rest for 5 to 8 hours before going home and having her recu-
perate at rest for five days, strings are removed a week afterward.
The site of grafting: Following the examples of YAGI, BUXTON-
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WONG, and SIPPEL, the rectal muscle has been selected for the site of
grafting.
The methods of determination: As reported in Part 1, methods
conventionally used in the determination are menstruation, the length of
uterine cavity, subjective symptoms, findings of the endometrium biopsy,
vaginal smear method, estimation of urinary hormones, urinary VAKAT
iodate index, the basal metabolism, basal body temperature, and histo-
logical examinations. Each of these has its advantage and disadvantage,
but since histological examination of the ovary runs counter to the pur·
pose of the present experiment, and as the determination of urinary
hormones of outpatients is difficult to carry on continuously for a long
time, these two were omitted and the other seven methods were employed.
Briefly speaking of examination methods, no special mention seems to be
necessary for menstruation, the length of uterine cavity and subjective
symptoms, and as for the smear method it has been applied in the same
manner as mentioned in Part 1. Concerning the basal body temperature
already mention was made, but in order to solve the problem presen <b d
in the case where the basal body temperature and the ovarian or the pro-
gesterone cycle did not coincide with one another as pointed out by
WHITLAw50, and WATANABE51 , findings on the endometrium biopsy were
referred to. Extirpation of the endometrium is conducted at high tempe-
rature in the case of the basal body temperature in biphase, while in the
case the basal body temperature is in monophase, it is done at intervals
of 15 to 20 days in the following manner: with a small modified form of
Meigs curet in order to avoid this manipulation from affecting the ovarian
function small pieces of endometrium are extirpated from three places,
the anterior and the posterior wall of the uterine cavity, and the site
of cancer, without enlarging the cervical canal. These samples are his-
tologically examined, and those showing identical secretion picture in
the range of = 3 days by dating biopsy of WATANABE52,53 are taken as
normal while others are considered to be insufficient.
With the use of Knipping apparatus after Saito's method the basal
metabolism is measured every two weeks, and the basal body temperature
in biphase is measured both at high and low temperature; and likewise
ovarian function has been determined all by his method.
OBSERVATION AND RESULTS
In the follow-up examinations carried on continuously for two months
before and about six months after operafion to the total of eight months
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by the methods mentioned above it as been found that the grafting proves
to be efficacious in all as shown in Tables 2 and 3, but the results are not
by any means uniform, varying as they do under various given conditions
of an individual case.
Studying from the standpoint of examination method, in the case
menstruation examination despite a good effect of grafting discernible of
the case without menstruation some occasionally demonstrated no menses
for a short period of time after grafting, proving the menstruation to be
an inadequate method for a precise determination. Although menses were
observed in all the 8 cases without menstruation to start with, everyone
of them revealed merely mense-like bleeding 3 to 6 months after grafting
as shown in Tables 3 and 4. As for the subjective symptom all the cases
complained somewhat prior to operation, but within one month of opera"
tion they were either completely cured or ameliorated. However, in this
instance one can not overlook psychological factors of the grafting on the
patient.
Next turning to the length of the uterine cavity, of the patients with
dysfunction of the ovary quite a few had normal-size ovary, namely,. 8
cases; and even in the cases showing an insufficient growth or atrophy
of the uterus, the enlargement of the uterus itself seems to occur as a
secondary phenomenon to the recovery of ovarian function. Therefore,
though showing a certain degree of the enlargement, it occurred invari-
ably 3 to 5 months after operation and only to a slight extent. The vagi-
nal smear, as emphasized by LEWIN, BUXTON·WONG, and WATANABE,
has been found to reflect the ovarian function most sensitively (Figs. 3,
4, 5), and even by this method alone it seems possible to know the total
alteration of the ovarian function.
There was not one case that showed the typical biphase in the basal
body temperature prior to operation. After grafting, however, the return
to normal conditions such as typical or atypical biphase, in the patients
indicating a tendency rather slightly toward dysfunction, was observable,
and in those apparently advanced cases the stability of the fluctuation
curve could only be discerned but no biphase.
In the determination of the basal metabolism after SAITO'S54 method
in our clinic, although it seems to have been possible to grasp rather
well the changes in the ovarian function, it yields unstable values during
the postoperative period. This is apparently due to the stress, grafting,
which affects the thyroid gland as well as the vegetative nerve sys-
tem.
As for the finding on the endometrial biopsy, in the proliferation
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phase it more or less parallels with the cornification index, and all the
cases whose basal body temperature is in biphase present secretion type,
while those in typical biphase the finding mostly coincides with dating
diagnosis and those in atypical biphase most of findings do not coincide
with the dating diagnosis. Those in monophase and having menstruation
present a picture less advanced than that of dating diagnosis, namely, a
secretion type indicating insufficient growth of the ovary.
In reviewing these results individually, it seems that often there is a
certain degree of variation in dysfunction according to different method
employed. Therefore, in the consideration of the degree of dysfunction
in the ovary it seems that over-all judgement of entire results obtained
by various methods needs to be taken into consideration. Looking over
the extent of dysfunction prior to operation and the course of recovery of
the grafted ovary from this view-point, they can be divided into three
grades according to the extent of effectiveness of grafting (Figs. 2, 3, 4).
The first grade effectiveness: Those that recovered the ovarian
function to the extent almost normal from the cycle immediately after
grafting and who had repeated almost normal cycles for six months (Fig. 2).
The second grade effectiveness: Those who had shown a certain
degree of effectiveness immediately after grafting but required several
months to return to the normal level; or those whose function returned
to relatively normal but still remained unstable; or those who had shown
no effect after grafting but about two months later began to show some
effect and returned to the normal level by six months later (Fig. 3).
The third grade effectiveness: Those who seemed to get no effect
after grafting began to show some improvement of the function about
third month and though they continued to improve but did not reach the
normal level by six months afterward (Fig. 4).
Effects of grafting to the various degrees were observable in every
case as shown in Table 2; but those who were considered to have dys-
function in advanced stage showed the third grade effectiveness and those
with slight dysfunction tended to show the first grade effectiveness. Mo-
reover, those whose function recovered back to the normal level main-
tained that state up to six months later; and even in those who had
shown the third grade effectiveness the effect of grafting, improving
gradually up to six months later, has never been found to lose its effec-
tiveness on the way to recovery, that is, to revert back again to a highly
dysfunctioning state.
On the other hand, with a view to study the relationship between
the type of blood and the effectiveness of grafting, all the 16 cases were
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Table 2.
Recipient I DonorNo. Name Effect
Agel Para /BlOOd I History I Degree .of IAgel paralBlood I Diagnosistype dysfunction type
1 Y.N. 26 Ox 0 I hypomenorrhea, intermittent menses light 38 4x 0 cancer St. I 1stdysmenorrhea, essential sterility grade
--
---
--
--- ---
hypomenorrhea, irregular menses (for2 T.K. 28 Ix B do. 41 7x A cancer St. H do.
--
--- --- ------
the past 3 yrs)
3 M.G. 28 Ix B intermittent menses (once in every 3-4 do. 28 3x 0 cancer St. 11 do.
---------~
months, for the past 3 yrs), dysmenorrhea
S.T.
hypomenorrhea (very small amount of menses
4 33 5x B for two day, starting 5 mos previously do. 45 9x AB cancer St. H do.
-------------
marked headache, dizziness, humming in ear
---
hypomenorrhea (from3yrs previously, menses erosion5 F. B. 25 Ox A once in every 4 mos), sterile for 13 yrs after do. 37 8x 0
endomet. do.
--
---
----
marriage, dysmenorrhea
6 N.K. 24 Ox A hypomenorrhea (once every 3 --4 mos), dysme- do. 32 3x B cancer St. I do.
--
----- ------
norrhea, sterile for 3 yrs after marriage
2nd I7 A. F. 24 Ox 0 -hypomenorrhea(menses twice a year), interm. 41 7x 0 cancer St. H
-----
marked headache and nausea grade
-- hypomenorrhea (ab-out twice a year), erosion8 T.H. 30 2x A
sterile for 7 yrs do. 37 8x B endomet. do.
-------
9 S.K. 37 2x A menses stopped ten mos previouly, headache, do. 42 5x A cancer St. I do.poor memory, adiposis
--
no menses for the past 4 yrs, when she had10 T.H. 37 Ox 0 do. 41 IX B cancer St. I do.
--
---
-----
menstruation, it was difficult m.
11 Y.M. 25 Ox A no menses for past 6 mos., hypomenorrhea, do. 42 5x A uterine myoma do.
-------
---
sterile (3 yrs since marriage)
12 N.K. 25 2x A no menses for the past 2 yrs. do. 42 3x A cancer do.
early St.
-----
no menses for the past 4 yrs. received treat-
cancer 3rd13 Y.N. 30 Ox B ment both before and after that period, high 41 Ix B
early St. grade
without any effect.
-------
---
menses stopped 11 mos ago, sterile (7 yrs14 K.M. 31 Ox 0 since marriage) do. 42 3x B do. do.
15 I. N. 31 Ix B no menses ever since 25 yrs old marked do.
1
32 5x B do. do.
stiff neck
-------
---
16 F.T. 29 Ox A no menses since she was 25 yrs old do. 42 2X AB cancer St. H do.
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Table. 3
No.
No.
I Name I
3[ M.T.
41 S. T.
Subjective
symptoms
systemic
ennervation
headache,
ringing ear
I Menstruation
hypomenorrhea, intermittent menses,
dymenorrhea
hypomenorrhea (a small amount for 2 days)
"tl
.,
o'
.,
...
o
o
'&
..,
~
o'
='
No. 5 F. B.
No.6N.K.
No. 9 S.K.
No. 10 T. H.
No. 11 Y. N.
do.
headache,
headache
hypomnesia
headache
diziness
menses once every 4 mos., dysmenorrhea
menses once evry 3-4 mos., dysmenorrhea
menses stopped ten mos. previously
menses stopped 4 yrs. ago
menses stopped 6 mos. ago, hypomenorrhea
No. 12 M. K. stiff neck menses stopped 4 yrs. ago
No. 13 Y. N. do. menses stopped 4 yrs. ago
No. 14 K.M. heaviness
of head do.
No. 3
1
M. G. ( - ) menst. cycle 40 days, amount normal
I
do., amount normal, no8 No. 6 N. K. (- ) dysmenorrhea
o ---
: No. 9 S. K. (-) a small amount of menses once a month
:::-~ No. 10 T. H. (_ ) an intermediate amount of menses to two days
and a very small amount for another day
No. 111 Y. N. ( - ) a very small amount of menses once in a cycle
No. 12
1
M. K. (-) none
a small amount for one day
do.
a very small amount for a day
none
do.
an intermediate amount for 3 days
a small amount for one day
do.
(- )
(-)No. 13 Y. N.
No. 11 Y.M.
No. 12 H. K.
No. 141 K. M. ( - )
----1--- 1-------1-------------------1
No. 3[ N. G. (-) menst. cycle 35 days, normal amount
No. 4j S. T. ( - ) normal
~ ~I F.B. (-)
8 No. 6 N. K. (-)
o
: No. 9 S. K. (-)
:::- -------1-------1---------------------1
~ No. 10 T. H. (- )
(-)
No. 14 K.M. (-) for a days in a small amount
6
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Basal body I Vaginal smear I Basal ISize of I Finding of the
temperature (cornification index) metabolism uterus endometrium
monophase non.cyclic (+)20-27% 7cm secretion stage(irregular) (20-30%) (insufficient)
atypical cyclic (+) (+) 13% 7cm do.biphase (max. 50%)
do. cyclic (-) (+)15-20% 6cm do.(max. 35%)
do. cyclic (-) (+) 25% 6.2cm do.(max. 41%)
monop.hase cyclic (-) 5.8% 5.6cm proliferation stage(max. 26%) (slight atrophy)
irregular type cyclic (-) (+) 30% 5.8cm do.(max. 32%)
do. cyclic (±) (+) 8-10% 5.4cm complete atrophy(max. 32%)
do. cyclic (±) (+ )24-31% 6cm do.(max. 29%)
monophase cyclic (-) (+) 15% 5.0cm do.(max. 20%)
do. cyclic (-) (+) 18% 7cm atrophy intermediate(max. 32%)
typical cyclic (+) (+) 12% 7cm normal (secretion stage)biphase ovulation p.70%
do. do. (+) 5% 7cm do.
do. cyclic (+) (+) 17% 6.2cm do.ovulation p.72%
do. cyclic (+) (+) 18% 6.4cm do.(max. 48%)
monophase cyclic (±) (+) 18%[ 5.7cm insufficient (secret stage)(max. 38%)
atypical cyclic (+) (+) 17% 6.0cm do.biphase (max. 50%)
typical biphase cyclic (+) (+) 22% 5.5cm slight atrophy secretion(max. 30%) insuffi.
do. cyclic (+) (+) 27% 6.3cm slight atrophy no(max . 4596) secretion
monophase cyclic (+) (+) 2496 5.2cm do.(max. 5896)
do. cyclic (-) (+) 8.1% 7cm do.(max. 3296)
typical biphase cycle (+) (+) 1296 7cm secretion period normal
ovulation 5596
do. do. 5796 (+) 3.2% 7cm do.
do. do. 62% (+) 13% 6.4cm do.
do. do. 4696 (+) 1296 6.5cm do.
atypical do. 4296 (+) 2096 5.8cm secretion periodbiphase insufficient
do. do. 5596 (+) 1296 6.2cm do.
typical do. 43% (+) 20% 5.6cm slight atropy secretionbiphase insufficient
do. do. 38% (+) 2496 6.4cm do.
atypical do. 4696 (+) 26% 5.3cm do.biphase
biphase do. 65% (+) 16% 7cm
7
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Fig. 2. The first grade effectiveness
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Fig. 3. The second grade effectiveness
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Fig. 4. Cases showing the third-grade effectiveness
lG~ 7
...
_ \\ :.Wt.~~.~~__II__~~_ .. ;:M ··~_w.•••~.·v ••••••••/•••/:·."'\'\'_"~..1-
·-·-·\;\!'V·.i\i'···,/··..vl,-·/·"v\N'r,'-A..,•.N-V'.."·
1 0 .+:----~.~-r-.t:----:t~-.+~--~.,.--••:--------...-.L-r-
lJ1.eM." a....e!SO.9% B.tte2.&% BH~:rI'l' 8.H.$23.~ B.H.S16.S". BH~.28·'" 8.H.es..~ lM.e'.fS
• .,...,. t
t .....(~c ~0J""t .ett.dom. cItto~~. ....t;c~.l. l . .,. t r- t
.z. ....c. .II'!'- ... a 1.".(.600II +.1.&1.(.6.2_ I.u.c. &.&
No.16 F.l.
divided into groups each of which had similar preoperative history and
examination results such as A, A', B, B', etc. (Table 2). The group,
ABC, was given grafting in conformance with requirements for blood
transfusion, and A'B'C' group was operated on counter to the require-
ments of blood trnsfusion: and as the result although some difference
could be observed between the two groups, it is believed that there was
no effect due to the type of blood (Table 2, refer to Figs. 2, 3, 4).
COMMENT
Homogenous grafting of the ovary to the patient with ovarian dys-
function has been tried by UNTERBERGER30, SIPPEL32•36, MANCLAIR56,
GUNSTER-SCHULTZE57, CRAMER58, LEOSER ALFRED, OHN043, NAKAYAMA,
etc59., and everyone of them report the efficacy of such a grafting. Not
all, however, are clarified about its effectiveness and there still remain
many problems to be solved. On the other hand, despite its complex
nature hormonal therapy as applied to the patient of ovarian function
seems, though not so conclusive as yet today, to play an important role
in the clarification of the problems arising out of re-examinations with
various methods on the efficacy of grafting the ovary that is usually dis-
carded at the time of gynecologic operation.
In every case, needless to say, a good effect of grafting has been
9
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recognized but there is no literature available explaining properly the
mechanism of appearance of this effect. In my experiment it has been
effective irrespective of success or failure of grafting itself, and also it
has been found the good effect appears at the stage immediately after
grafting, namely, before the grafted ovary begins its activity. From this
it would appear, as ORNO and SIPPEL55 contend, that the tissue of the
grafted ovary in some manner stimulates the indigenous ovary, leading
its function back to normal; and therefore, the recovery of the function
should not be considered as due to the secretion of hormones by the grafted
ovary. It is believed that the ability to react to such a stimulation and
the degree of dysfunction of the indigenous ovary are the deciding factors
on the effect of grafting, and that difference in the combination of these
factors makes the time of appearance and the degree of effect variable.
That the case of severe dysfunction mentioned previously tended to show
the third grade effectiveness seems to lie in the fact that the majority of
these ovaries possessed a weak-reaction power.
As already mentioned no relationship can be recognized between the
type of blood and the effectiveness. However, in Group ABC where the
grafting was supposedly successful and consequently whose grafted ovary
was thought to be secreting hormones, yet it was difficult to distinguish
the activity of the grafted ovary from that of the indigenous ovary; and
there is no literature available explaining this point. Again, despite the
fact that the indigenous ovary is assumed to be acting in conjunction with
the grafted ovary, the reason why there is not any appreciable difference
between the successfully grafted group and the group of failure seems to
be due to the fact that activity of the grafted ovary in the presence of an
indigenous ovary, as in the case of the activity of the grafted ovary in
castrated woman, is not so marked.
Finally, as regards the danger of transplanting cancer cells at the
time of grafting, by the investigations of NAGAl60 of our department and
by the fact that in 946 cases of auto-transplantation conducted in the
Gynecology Department of Okayama University at the time of extensive
hysterectomy without any cancer growth, it may be said there is no such
a danger. However, as a matter of assurance in my own experiment I
have taken out small pieces from ovarian tissue and verified histologically
that there is no cancer infiltration.
SUMMARY
Homogenous grafting of the ovary to patients of ovarian dysfunction
all proved to be effective, but the degree of the effectiveness and the time
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of appearance of effect of the grafting were not fixed.
Moreover, there was no relationship between the effectiveness of
grafting and the type of blood.
If the various conditions at the time of grafting are taken into· consid-
eration as above mentioned, this operation utilizing as it does the ovary
usually discarded at operation may be expected to bring about quite a
satisfactory therapeutic result.
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